Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.

Transplants Community

This patient support community is for discussions relating to transplants, anti-rejection drugs, financial and insurance issues, long-term issues, organ rejection, pre- and post-surgery, and waiting list issues.
 | 

MELD SCORE

by mikesimon, May 16, 2008 10:23AM
I think anyone waiting for a liver transplant will find this article of significant interest. This is the section on MELD score but the article addresses the following issues:  
  
    * General Principles and Natural History of Cirrhosis
    * Child's Score
    * Meld Score
    * Meld Score Derivatives
    * Prognosis According to Specific Causes of Cirrhosis
    * Prognosis in the Particular Setting of Nontransplant Surgery
    * Prognosis in the Particular Setting of the Intensive Care Unit
    * Prognosis in the Particular Setting of Transplantation
    * Which Prognostic Tool to Use for Assessing the Prognosis of Cirrhosis?
    * Perspectives: Beyond MELD Score

The entire article is at:  http://www.medscape.com/viewarticle/572659_11


Meld Score
Definitions

While Child score was originally designed for assessing the prognosis of cirrhotic patients undergoing surgical treatment of portal hypertension, MELD score was designed for assessing the prognosis of cirrhotic patients
undergoing transjugular portosystemic intrahepatic shunt (TIPS).[24] Multivariate analysis using Cox regression analysis showed that among a list of pre-determined variables, four variables had an independent impact on survival, namely bilirubin, creatinine, INR, and the cause of cirrhosis (alcoholic and cholestatic versus other causes). To lessen the influence of extreme values, the natural logarithm of bilirubin INR and creatinine were entered into the model. Based on regression analysis, a coefficient was attached to each variable, according to the weight of each variable on mortality risk. In the original series, the resulting score was slightly more accurate than Child-Pugh score for predicting survival after TIPS.

With the expansion of liver transplantation, attention moved from the management of portal hypertension to waiting list mortality and organ allocation policy in patients listed for transplantation. Indeed, waiting time alone proved to be an inaccurate marker of waiting list mortality[27] and more relevant markers were needed. A slightly modified risk score, termed the MELD score, was tested in populations of cirrhotic patients for assessing early (3 months) mortality risk after placement on the waiting list.[28] This modified score proved to be a robust marker of early mortality which could be generalized to patients with various causes of cirrhosis and various degrees of severity. Excluding the variable “cause of cirrhosis” had a minimal impact on the model accuracy. As a result, a simplified version of MELD score including only three objective variables (bilirubin, creatinine, and INR) was eventually proposed for easier use ( Table 3 ).[29] According to this modified score, patients with bilirubin and creatinine values below 1 mg/dL (17 and 90 μmol/L, respectively) are rounded off to 1 mg/dL to avoid negative logarithmic values. Similarly, patients with INR below 1 are rounded off to 1. Whatever the individual values, the score is empirically capped at 40. Consequently, MELD score represents a continuous variable ranging from 6 to 40.
Applications

MELD score has been adopted since 2002 for organ allocation to patients listed for liver transplantation in the United States.[30] According to the MELD-based policy, patients with the highest score have a priority for organ allocation. More recently, MELD score has also been adopted in several European countries as well as in South America. The impact of MELD score on liver transplantation is discussed below.

In addition to organ allocation, several studies have confirmed that MELD score is a reliable tool for predicting outcome after TIPS.[31,32] The “c” statistic represents a global estimate of the ability of a score to predict an event. This statistic, which is derived from the area under the receiver operating characteristic curve, ranges from 0 to 1. A “c” statistic of 0.5 means that the score is of no value for predicting a given event. A “c” statistic of 1 means that the score is perfect (a goal which is never achieved in clinical practice). The “c” statistic of the MELD score for predicting 1-year survival after TIPS is ∼0.7, which means that it is clinically useful. MELD score also proved to be a reliable marker of 1-year and 5-year survival across a broad spectrum of liver diseases including alcoholic cirrhosis and alcoholic hepatitis.[33] In addition, MELD score has been shown to be a good prognostic marker in cases of variceal bleeding,[34] spontaneous bacterial peritonitis,[35] and hepatorenal syndrome.[36] Independent of the cause of cirrhosis, high MELD score was shown to be associated with a decrease in residual liver function as measured by monoethylglycinexylidine test.[37] The particular issues of alcoholic cirrhosis, HCC, nontransplant surgery, and transplantation are detailed below.
Limitations

Using statistical analysis rather than empirical selection of variables for establishing a prognostic score can be anticipated as more rigorous, on a methodological basis, and eventually, more efficacious. However, it must be kept in mind that even if the three components of the MELD score have been selected on the basis of a statistical analysis, all the variables entered in the model have been empirically selected, because they were felt to have an influence on the outcome or, more simply, because they were available. It cannot be excluded that other important variables may not have been taken into account.

The three variables entered in the MELD score (bilirubin, creatinine, and INR) are supposed to be objective (in contrast to ascites and encephalopathy, the grading of which is subjective). However, even these “objective” markers may be subjected to significant variations resulting from either changes over time or from different laboratory methodologies. There are substantial interlaboratory variations in INR depending on the methods used for determination. It has been shown that interlaboratory variation in INR is ∼25%. Among the three variables of MELD score, INR has the highest multiplicative value. Therefore variations in INR may translate to up to 20% differences in MELD score.[38] In single individuals with cirrhosis, substantial changes in serum creatinine may occur, especially in those undergoing large-volume paracentesis and/or receiving diuretics. Laboratory methods may also interfere with the value of serum creatinine. There is a poor agreement among different creatinine assays, especially as serum bilirubin rises.[39] Overall, MELD score is not as objective as it was expected to be.

A major limitation of MELD score is the need for computation, which makes it less friendly to use than Child-Pugh score at the bedside. Logarithmic transformation has been chosen to optimize the statistical model. Originally, this statistical model and the derived score were not designed to be routinely used in clinical practice. With the expansion of MELD score in many fields of hepatology, the need for computation represents a source of difficulties. There is no evidence that a simplified score based on the original values of bilirubin, INR, and creatinine (without logarithmic transformation) would be less accurate. In addition, there are no clear-cut values of MELD score for easily categorizing individual patients according to their own mortality risk.

From:  Assessment of Prognosis of Cirrhosis
Posted 04/28/2008
François Durand, M.D.; Dominique Valla, M.D.
Member Comments (28)

by child24angel, May 16, 2008 11:48AM
To: Mike
Another good article  Thank you
Hugs
Elaine

by mikesimon, May 23, 2008 10:50AM
To: Child24Angel
You're welcome Elaine. Mike

by IAmTheWalrus, May 24, 2008 03:48AM
To: Mike
That article looks like it doesn't change much for the present system, but explores where some improvements and gains might cme from in the future. Of particular interest to me was the use of MELD score for HCC patients. Since my tumor was benign, it appears that I took greater risk with the surgery and possible could a have treated at that point since my liver was at least partially comensated. Could have been a dicey decision, a crazy decision based on the HCC diagnosis. Anyway, I am not sorry for the outcome. I think there were a lot of benefits before I reached a place where I was hospitalized before transplant.

I understand the system and its strengths and weaknesses better now. Thanks again for the up-to-date data.

Brent

by eureka254, Jun 01, 2008 10:24PM
To: Mike/IAmTheWalrus
Mike:  Thanks for the article!  I'm trying to understand the whole MELD scoring system as well as trying to learn about the process leading to transplant.  Every bit of info helps, but I still don't quite get how the HCC component plays into the MELD score (or does it?)

Walrus:   I'm very curious (if you don't mind) as to the circumstances that led to your transplant... was it immediately pursued at the time of tumor diagnosis?  Was it your MELD score that put you on the transplant list, or the presence of tumor, or both?  My husband has well-compensated cirrhosis, but he had liver resection for a tumor that was HCC last year.  His CT scan 2 weeks ago showed a couple of echogenic spots -- doc said could be nothing, could be the start of HCC -- so I'm trying to arm myself with as much knowledge as I can before the next CT Scan in August.  (I've heard that if there are more than 2 tumors, it disqualifies one for transplant... is that true?)

Thanks for any input.

by mikesimon, Jun 02, 2008 07:00AM
To: Eureka
I don't know precisely how HCC is factored in but I do know that it bumps you up the list. I believe most centers follow that Milan criteria - transplant is considered when a patient has one nodule less than 5 cm or 3 or less nodules and none larger than 3 cm. I think that's right but without checking I can't be sure. Mike

by eureka254, Jun 03, 2008 12:32AM
To: Mikesimon/All
So... if a patient has cirrhosis and a low MELD score... would the occurrence of HCC make him a candidate for transplant?  Or does the MELD score have to reach a minimum value before consideration for transplant?  (At what MELD score is someone eligible to be on the transplant list?)

Thanks for your input.

by child24angel, Jun 03, 2008 06:59AM
To: eureka
Hi Eureka
If the patient has HCC that will
make him a  candidate for TP regardless
of MELD score (my understanding)
Moves him to the top of the list if HCC is
suspected.
I believe each region is different however,
you can be listed as low as an 8. (my understanding)
Good Luck to you and your husband
Hugs
Elaine

by merryBe, Jun 03, 2008 11:21PM
To: mikesimon
thanks for posting this. Of course, how one would convince a doctor Meld might not be accurate becomes the next question.
Still, it's good to know ones misgivings may have basis.I'm fairly certain my Meld does not reflect my true stage and state, so  this is at least a starting point now.
appreciate it.
mb